Clinical Trial Update: Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 clinical trial from Institut Curie is evaluating ocular conservative treatment strategies for retinoblastoma, focusing on efficacy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: Institut Curie | Conditions: Retinoblastoma | Phase 2, Phase 3 | Status: RECRUITING